Charles Schwab’s US Physical Therapy USPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.42M | Sell |
137,129
-9,839
| -7% | -$669K | ﹤0.01% | 2191 |
|
|
2026
Q1 | $11M | Sell |
146,968
-920
| -0.6% | -$75.4K | ﹤0.01% | 2049 |
|
|
2025
Q4 | $11.5M | Buy |
147,888
+5,207
| +4% | +$423K | ﹤0.01% | 2064 |
|
|
2025
Q3 | $12.1M | Buy |
142,681
+3,613
| +3% | +$289K | ﹤0.01% | 2022 |
|
|
2025
Q2 | $10.9M | Buy |
139,068
+4,570
| +3% | +$337K | ﹤0.01% | 1969 |
|
|
2025
Q1 | $9.73M | Sell |
134,498
-7,169
| -5% | -$602K | ﹤0.01% | 1963 |
|
|
2024
Q4 | $12.6M | Sell |
141,667
-7,234
| -5% | -$645K | ﹤0.01% | 1913 |
|
|
2024
Q3 | $12.6M | Sell |
148,901
-6,140
| -4% | -$545K | ﹤0.01% | 1921 |
|
|
2024
Q2 | $14.3M | Sell |
155,041
-3,609
| -2% | -$365K | ﹤0.01% | 1862 |
|
|
2024
Q1 | $17.9M | Buy |
158,650
+6,551
| +4% | +$654K | ﹤0.01% | 1679 |
|
|
2023
Q4 | $14.2M | Buy |
152,099
+2,063
| +1% | +$182K | ﹤0.01% | 1809 |
|
|
2023
Q3 | $13.8M | Buy |
150,036
+8,314
| +6% | +$893K | ﹤0.01% | 1733 |
|
|
2023
Q2 | $17.2M | Buy |
141,722
+10,591
| +8% | +$1.14M | ﹤0.01% | 1603 |
|
|
2023
Q1 | $12.8M | Buy |
131,131
+1,826
| +1% | +$174K | ﹤0.01% | 1747 |
|
|
2022
Q4 | $10.5M | Buy |
129,305
+3,177
| +3% | +$267K | ﹤0.01% | 1825 |
|
|
2022
Q3 | $9.59M | Buy |
126,128
+5,349
| +4% | +$514K | ﹤0.01% | 1862 |
|
|
2022
Q2 | $13.2M | Buy |
120,779
+2,515
| +2% | +$267K | ﹤0.01% | 1680 |
|
|
2022
Q1 | $11.8M | Buy |
118,264
+6,500
| +6% | +$620K | ﹤0.01% | 1862 |
|
|
2021
Q4 | $10.7M | Buy |
111,764
+8,722
| +8% | +$874K | ﹤0.01% | 1968 |
|
|
2021
Q3 | $11.4M | Buy |
103,042
+6,611
| +7% | +$753K | ﹤0.01% | 1928 |
|
|
2021
Q2 | $11.2M | Buy |
96,431
+6,366
| +7% | +$731K | ﹤0.01% | 1935 |
|
|
2021
Q1 | $9.38M | Buy |
90,065
+5,526
| +7% | +$687K | ﹤0.01% | 1995 |
|
|
2020
Q4 | $10.2M | Buy |
84,539
+502
| +0.6% | +$50.7K | ﹤0.01% | 1861 |
|
|
2020
Q3 | $7.3M | Sell |
84,037
-1,774
| -2% | -$153K | ﹤0.01% | 1872 |
|
|
2020
Q2 | $6.95M | Buy |
85,811
+6,946
| +9% | +$507K | ﹤0.01% | 1866 |
|
|
2020
Q1 | $5.44M | Buy |
78,865
+1,326
| +2% | +$140K | ﹤0.01% | 1793 |
|
|
2019
Q4 | $8.87M | Buy |
77,539
+1,420
| +2% | +$177K | ﹤0.01% | 1717 |
|
|
2019
Q3 | $9.94M | Buy |
76,119
+1,676
| +2% | +$218K | 0.01% | 1609 |
|
|
2019
Q2 | $9.13M | Buy |
74,443
+2,706
| +4% | +$311K | 0.01% | 1648 |
|
|
2019
Q1 | $7.54M | Buy |
71,737
+2,856
| +4% | +$307K | ﹤0.01% | 1755 |
|
|
2018
Q4 | $7.05M | Sell |
68,881
-519
| -0.7% | -$57.6K | 0.01% | 1689 |
|
|
2018
Q3 | $8.23M | Buy |
69,400
+2,895
| +4% | +$327K | 0.01% | 1765 |
|
|
2018
Q2 | $6.38M | Buy |
66,505
+1,321
| +2% | +$123K | ﹤0.01% | 1870 |
|
|
2018
Q1 | $5.3M | Buy |
65,184
+5,500
| +9% | +$426K | ﹤0.01% | 1907 |
|
|
2017
Q4 | $4.31M | Buy |
59,684
+3,174
| +6% | +$217K | ﹤0.01% | 1996 |
|
|
2017
Q3 | $3.47M | Buy |
56,510
+2,873
| +5% | +$175K | ﹤0.01% | 2065 |
|
|
2017
Q2 | $3.24M | Buy |
53,637
+541
| +1% | +$34.6K | ﹤0.01% | 2029 |
|
|
2017
Q1 | $3.47M | Buy |
53,096
+2,490
| +5% | +$176K | ﹤0.01% | 1962 |
|
|
2016
Q4 | $3.55M | Buy |
50,606
+2,522
| +5% | +$160K | ﹤0.01% | 1920 |
|
|
2016
Q3 | $3.02M | Buy |
48,084
+2,062
| +4% | +$127K | ﹤0.01% | 1925 |
|
|
2016
Q2 | $2.77M | Buy |
46,022
+810
| +2% | +$44.4K | ﹤0.01% | 1917 |
|
|
2016
Q1 | $2.25M | Buy |
45,212
+899
| +2% | +$44.7K | ﹤0.01% | 1992 |
|
|
2015
Q4 | $2.38M | Buy |
44,313
+1,283
| +3% | +$64.3K | ﹤0.01% | 1993 |
|
|
2015
Q3 | $1.93M | Buy |
43,030
+7,538
| +21% | +$376K | ﹤0.01% | 2083 |
|
|
2015
Q2 | $1.94M | Buy |
35,492
+984
| +3% | +$48.7K | ﹤0.01% | 2121 |
|
|
2015
Q1 | $1.64M | Buy |
34,508
+1,392
| +4% | +$59.2K | ﹤0.01% | 2166 |
|
|
2014
Q4 | $1.39M | Sell |
33,116
-1,289
| -4% | -$50.7K | ﹤0.01% | 2197 |
|
|
2014
Q3 | $1.22M | Buy |
34,405
+714
| +2% | +$25.2K | ﹤0.01% | 2212 |
|
|
2014
Q2 | $1.15M | Sell |
33,691
-224
| -0.7% | -$7.23K | ﹤0.01% | 2252 |
|
|
2014
Q1 | $1.17M | Buy |
33,915
+840
| +3% | +$27.9K | ﹤0.01% | 2211 |
|
|
2013
Q4 | $1.17M | Buy |
33,075
+4,508
| +16% | +$148K | ﹤0.01% | 2195 |
|
|
2013
Q3 | $908K | Buy |
28,567
+1,358
| +5% | +$40.1K | ﹤0.01% | 2257 |
|
|
2013
Q2 | $762K | Buy |
+27,209
| New | +$719K | ﹤0.01% | 2309 |
|
Other funds holding USPH
BG
CCM
SAM
Charles Schwab's USPH Position: Q2 2026 in Review
Charles Schwab reduced its US Physical Therapy (USPH) stake by 6.7% in Q2 2026, selling an estimated $669K and leaving 137,129 shares worth $9.42M. The position accounts for ﹤0.01% of the portfolio, ranked #2191.
Charles Schwab first reported a position in USPH in Q2 2013 and has held it in 53 quarters since. The position peaked at $17.9M in Q1 2024. 217 funds tracked by Wall St. Rank hold USPH as of Q2 2026.
- Charles Schwab held 137,129 shares of US Physical Therapy worth $9.42M as of Q2 2026.
- Charles Schwab sold 9,839 US Physical Therapy shares in Q2 2026, an estimated $669K.
- US Physical Therapy made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #2191 holding.
- Charles Schwab first reported a position in US Physical Therapy in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's US Physical Therapy position peaked at $17.9M in Q1 2024.
- 217 funds tracked by Wall St. Rank held US Physical Therapy as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.